Amy Ly

58 papers receiving 1.1k citations

Peers

Amy Ly
Comparison fields: 5 of 104
  • Virology 294
  • Cancer Research 211
  • Immunology 225
  • Oncology 231
  • Infectious Diseases 129
Replace Silvia Behnke with:
Silvia Behnke Switzerland
Magnus Sundström Sweden
Paola Cafforio Italy
L. Bronz Switzerland
Christophe Picard France
Yuri Fedoriw United States
Sophie Krieger France
Tessa Kerre Belgium
Jeffrey M. Gerold United States
Ricardo Mesa‐Tejada United States
Amy Ly relative to Silvia Behnke Switzerland Silvia Behnke's profile →
Citations per field
00.5×3.1×
Silvia Behnke · 1×
Citations per year

Countries citing papers authored by Amy Ly

Since Specialization
Citations

This map shows the geographic impact of Amy Ly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Ly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Ly more than expected).

Fields of papers citing papers by Amy Ly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Ly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Ly. The network helps show where Amy Ly may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy Ly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy Ly Line = papers co-authored together Amy Ly links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2001186
2 2000126
3 201492
4 201575
5 201351
6 201351
7 202348
8 202046
9 201734
10 201430
11 201628
12 201624
13 202320
14 202118
15 202417
16 201017
17 201715
18 202213
19 202012
20 201512

About Amy Ly

Amy Ly is a scholar working on Cancer Research, Pathology and Forensic Medicine, Health Informatics, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 63 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (12 papers), Radiomics and Machine Learning in Medical Imaging (7 papers), Cancer Genomics and Diagnostics (6 papers), AI in cancer detection (6 papers), HER2/EGFR in Cancer Research (5 papers), Salivary Gland Tumors Diagnosis and Treatment (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Virology (294 citations), Cancer Research (211 citations), Immunology (225 citations), Oncology (231 citations) and Infectious Diseases (129 citations). Amy Ly has collaborated with scholars based in United States, Australia and Belgium. Frequent co-authors include Leonidas Stamatatos, Elena F. Brachtel, Deborah Dillon, Susan C. Lester, Innocent Mboudjeka, I Srivastava, Susan W. Barnett, Ying Lian, John R. Mascola and Clarisa M. Buckner. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal of Thoracic Oncology, Human Pathology and Journal of the National Comprehensive Cancer Network.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026